APO Research

APO RESEARCH · REPORT

Budesonide Sprays

Selected research

Market Structure

Global Budesonide Sprays Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Budesonide Sprays market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Budesonide Sprays is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Budesonide Sprays is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Budesonide Sprays is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Budesonide Sprays is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Budesonide Sprays include Abbott, Takeda, Teva, Sandoz, Novartis, Mylan, Pfizer, AstraZeneca and Wellcome Australia Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Budesonide Sprays market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Budesonide Sprays and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Budesonide Sprays sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Budesonide Sprays market size, projected growth trends, production technologies, key applications, and end-use industries.

Budesonide Sprays Segment by Company

Abbott

Takeda

Teva

Sandoz

Novartis

Mylan

Pfizer

AstraZeneca

Wellcome Australia Ltd

Synmosa Biopharma Corporation

Squibb

Skyepharma

Shimadzu Corp

Shanghai Sine Pharmaceutical

Manus Aktteva Biopharma LLP

Lunan Better Pharmaceutical

Cipla

Chiesi Farmaceutici S.p.A

Boehringer Ingelheim

Allgen Pharmaceuticals

Budesonide Sprays Segment by Type

32ug*120 Spray

64ug*120 Spray

Other

Budesonide Sprays Segment by Application

Hospitals

Clinics

Other

Budesonide Sprays Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide Sprays market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Budesonide Sprays and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide Sprays.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Budesonide Sprays market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Budesonide Sprays manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Budesonide Sprays in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Budesonide Sprays in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Budesonide Sprays Industry Trends Table 2. Budesonide Sprays Industry Drivers Table 3. Budesonide Sprays Industry Opportunities and Challenges Table 4. Budesonide Sprays Industry Restraints Table 5. Global Budesonide Sprays Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Budesonide Sprays Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Budesonide Sprays Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Budesonide Sprays Sales Market Share by Manufacturers Table 9. Global Budesonide Sprays Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Budesonide Sprays Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Budesonide Sprays Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Budesonide Sprays Manufacturers, Product Type & Application Table 13. Global Budesonide Sprays Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Budesonide Sprays by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 32ug*120 Spray Table 17. Major Manufacturers of 64ug*120 Spray Table 18. Major Manufacturers of Other Table 19. Global Budesonide Sprays Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Budesonide Sprays Sales by Type (2021-2026) & (K Units) Table 21. Global Budesonide Sprays Sales by Type (2027-2032) & (K Units) Table 22. Global Budesonide Sprays Sales Market Share by Type (2021-2026) Table 23. Global Budesonide Sprays Sales Market Share by Type (2027-2032) Table 24. Global Budesonide Sprays Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Budesonide Sprays Revenue by Type (2021-2026) & (K Units) Table 26. Global Budesonide Sprays Revenue by Type (2027-2032) & (K Units) Table 27. Global Budesonide Sprays Revenue Market Share by Type (2021-2026) Table 28. Global Budesonide Sprays Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Other Table 32. Global Budesonide Sprays Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Budesonide Sprays Sales by Application (2021-2026) & (K Units) Table 34. Global Budesonide Sprays Sales by Application (2027-2032) & (K Units) Table 35. Global Budesonide Sprays Sales Market Share by Application (2021-2026) Table 36. Global Budesonide Sprays Sales Market Share by Application (2027-2032) Table 37. Global Budesonide Sprays Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Budesonide Sprays Revenue by Application (2021-2026) & (K Units) Table 39. Global Budesonide Sprays Revenue by Application (2027-2032) & (K Units) Table 40. Global Budesonide Sprays Revenue Market Share by Application (2021-2026) Table 41. Global Budesonide Sprays Revenue Market Share by Application (2027-2032) Table 42. Global Budesonide Sprays Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Budesonide Sprays Sales by Region (2021-2026) & (K Units) Table 44. Global Budesonide Sprays Sales Market Share by Region (2021-2026) Table 45. Global Budesonide Sprays Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Budesonide Sprays Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Budesonide Sprays Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Budesonide Sprays Sales by Country (2021-2026) & (K Units) Table 49. North America Budesonide Sprays Sales by Country (2027-2032) & (K Units) Table 50. Europe Budesonide Sprays Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Budesonide Sprays Sales by Country (2021-2026) & (K Units) Table 52. Europe Budesonide Sprays Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Budesonide Sprays Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Budesonide Sprays Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Budesonide Sprays Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Budesonide Sprays Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Budesonide Sprays Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Budesonide Sprays Sales by Country (2027-2032) & (K Units) Table 59. Global Budesonide Sprays Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Budesonide Sprays Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Budesonide Sprays Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Budesonide Sprays Revenue Market Share by Region (2021-2026) Table 63. Global Budesonide Sprays Revenue Market Share by Region (2027-2032) Table 64. Abbott Company Information Table 65. Abbott Business Overview Table 66. Abbott Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Abbott Budesonide Sprays Product Portfolio Table 68. Abbott Recent Development Table 69. Takeda Company Information Table 70. Takeda Business Overview Table 71. Takeda Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Takeda Budesonide Sprays Product Portfolio Table 73. Takeda Recent Development Table 74. Teva Company Information Table 75. Teva Business Overview Table 76. Teva Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Teva Budesonide Sprays Product Portfolio Table 78. Teva Recent Development Table 79. Sandoz Company Information Table 80. Sandoz Business Overview Table 81. Sandoz Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Sandoz Budesonide Sprays Product Portfolio Table 83. Sandoz Recent Development Table 84. Novartis Company Information Table 85. Novartis Business Overview Table 86. Novartis Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Novartis Budesonide Sprays Product Portfolio Table 88. Novartis Recent Development Table 89. Mylan Company Information Table 90. Mylan Business Overview Table 91. Mylan Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Mylan Budesonide Sprays Product Portfolio Table 93. Mylan Recent Development Table 94. Pfizer Company Information Table 95. Pfizer Business Overview Table 96. Pfizer Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Pfizer Budesonide Sprays Product Portfolio Table 98. Pfizer Recent Development Table 99. AstraZeneca Company Information Table 100. AstraZeneca Business Overview Table 101. AstraZeneca Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. AstraZeneca Budesonide Sprays Product Portfolio Table 103. AstraZeneca Recent Development Table 104. Wellcome Australia Ltd Company Information Table 105. Wellcome Australia Ltd Business Overview Table 106. Wellcome Australia Ltd Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Wellcome Australia Ltd Budesonide Sprays Product Portfolio Table 108. Wellcome Australia Ltd Recent Development Table 109. Synmosa Biopharma Corporation Company Information Table 110. Synmosa Biopharma Corporation Business Overview Table 111. Synmosa Biopharma Corporation Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Synmosa Biopharma Corporation Budesonide Sprays Product Portfolio Table 113. Synmosa Biopharma Corporation Recent Development Table 114. Squibb Company Information Table 115. Squibb Business Overview Table 116. Squibb Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Squibb Budesonide Sprays Product Portfolio Table 118. Squibb Recent Development Table 119. Skyepharma Company Information Table 120. Skyepharma Business Overview Table 121. Skyepharma Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Skyepharma Budesonide Sprays Product Portfolio Table 123. Skyepharma Recent Development Table 124. Shimadzu Corp Company Information Table 125. Shimadzu Corp Business Overview Table 126. Shimadzu Corp Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Shimadzu Corp Budesonide Sprays Product Portfolio Table 128. Shimadzu Corp Recent Development Table 129. Shanghai Sine Pharmaceutical Company Information Table 130. Shanghai Sine Pharmaceutical Business Overview Table 131. Shanghai Sine Pharmaceutical Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Shanghai Sine Pharmaceutical Budesonide Sprays Product Portfolio Table 133. Shanghai Sine Pharmaceutical Recent Development Table 134. Manus Aktteva Biopharma LLP Company Information Table 135. Manus Aktteva Biopharma LLP Business Overview Table 136. Manus Aktteva Biopharma LLP Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Manus Aktteva Biopharma LLP Budesonide Sprays Product Portfolio Table 138. Manus Aktteva Biopharma LLP Recent Development Table 139. Lunan Better Pharmaceutical Company Information Table 140. Lunan Better Pharmaceutical Business Overview Table 141. Lunan Better Pharmaceutical Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Lunan Better Pharmaceutical Budesonide Sprays Product Portfolio Table 143. Lunan Better Pharmaceutical Recent Development Table 144. Cipla Company Information Table 145. Cipla Business Overview Table 146. Cipla Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Cipla Budesonide Sprays Product Portfolio Table 148. Cipla Recent Development Table 149. Chiesi Farmaceutici S.p.A Company Information Table 150. Chiesi Farmaceutici S.p.A Business Overview Table 151. Chiesi Farmaceutici S.p.A Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Chiesi Farmaceutici S.p.A Budesonide Sprays Product Portfolio Table 153. Chiesi Farmaceutici S.p.A Recent Development Table 154. Boehringer Ingelheim Company Information Table 155. Boehringer Ingelheim Business Overview Table 156. Boehringer Ingelheim Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Boehringer Ingelheim Budesonide Sprays Product Portfolio Table 158. Boehringer Ingelheim Recent Development Table 159. Allgen Pharmaceuticals Company Information Table 160. Allgen Pharmaceuticals Business Overview Table 161. Allgen Pharmaceuticals Budesonide Sprays Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Allgen Pharmaceuticals Budesonide Sprays Product Portfolio Table 163. Allgen Pharmaceuticals Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Budesonide Sprays Distributors List Table 167. Budesonide Sprays Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Budesonide Sprays Product Image Figure 2. Global Budesonide Sprays Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Budesonide Sprays Market Size (2021-2032) & (US$ Million) Figure 4. Global Budesonide Sprays Sales (2021-2032) & (K Units) Figure 5. Global Budesonide Sprays Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Budesonide Sprays Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 32ug*120 Spray Image Figure 9. 64ug*120 Spray Image Figure 10. Other Image Figure 11. Global Budesonide Sprays Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Budesonide Sprays Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Budesonide Sprays Sales Market Share by Type (2021-2032) Figure 14. Global Budesonide Sprays Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Budesonide Sprays Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Budesonide Sprays Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Other Image Figure 20. Global Budesonide Sprays Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Budesonide Sprays Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Budesonide Sprays Sales Market Share by Application (2021-2032) Figure 23. Global Budesonide Sprays Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Budesonide Sprays Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Budesonide Sprays Revenue Market Share by Application (2021-2032) Figure 26. North America Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Budesonide Sprays Sales Market Share by Country (2021-2032) Figure 28. U.S. Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Budesonide Sprays Sales Market Share by Country (2021-2032) Figure 33. Germany Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Budesonide Sprays Sales Market Share by Country (2021-2032) Figure 40. China Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Budesonide Sprays Sales Market Share by Country (2021-2032) Figure 48. Brazil Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Budesonide Sprays Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Budesonide Sprays Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Budesonide Sprays Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Budesonide Sprays Revenue (2021-2032) & (US$ Million) Figure 59. North America Budesonide Sprays Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Budesonide Sprays Revenue (2021-2032) & (US$ Million) Figure 61. Europe Budesonide Sprays Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Budesonide Sprays Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Budesonide Sprays Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Budesonide Sprays Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Budesonide Sprays Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Budesonide Sprays Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Budesonide Sprays Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 32ug*120 Spray
  • 64ug*120 Spray
  • Other
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Abbott
  • Takeda
  • Teva
  • Sandoz
  • Novartis
  • Mylan
  • Pfizer
  • AstraZeneca
  • Wellcome Australia Ltd
  • Synmosa Biopharma Corporation
  • Squibb
  • Skyepharma
  • Shimadzu Corp
  • Shanghai Sine Pharmaceutical
  • Manus Aktteva Biopharma LLP
  • Lunan Better Pharmaceutical
  • Cipla
  • Chiesi Farmaceutici S.p.A
  • Boehringer Ingelheim
  • Allgen Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Budesonide Sprays Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Budesonide Sprays Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Budesonide Sprays Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Budesonide Sprays Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Budesonide Sprays Market Dynamics
  1. 2.1 Budesonide Sprays Industry Trends
  2. 2.2 Budesonide Sprays Industry Drivers
  3. 2.3 Budesonide Sprays Industry Opportunities and Challenges
  4. 2.4 Budesonide Sprays Industry Restraints
3 Budesonide Sprays Market by Manufacturers
  1. 3.1 Global Budesonide Sprays Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Budesonide Sprays Sales by Manufacturers (2021-2026)
  3. 3.3 Global Budesonide Sprays Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Budesonide Sprays Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Budesonide Sprays Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Budesonide Sprays Manufacturers, Product Type & Application
  7. 3.7 Global Budesonide Sprays Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Budesonide Sprays Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Budesonide Sprays Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Budesonide Sprays Tier 1, Tier 2, and Tier 3
4 Budesonide Sprays Market by Type
  1. 4.1 Budesonide Sprays Type Introduction
  2. 4.1.1 32ug*120 Spray
  3. 4.1.2 64ug*120 Spray
  4. 4.1.3 Other
  5. 4.2 Global Budesonide Sprays Sales by Type
  6. 4.2.1 Global Budesonide Sprays Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Budesonide Sprays Sales by Type (2021-2032)
  8. 4.2.3 Global Budesonide Sprays Sales Market Share by Type (2021-2032)
  9. 4.3 Global Budesonide Sprays Revenue by Type
  10. 4.3.1 Global Budesonide Sprays Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Budesonide Sprays Revenue by Type (2021-2032)
  12. 4.3.3 Global Budesonide Sprays Revenue Market Share by Type (2021-2032)
5 Budesonide Sprays Market by Application
  1. 5.1 Budesonide Sprays Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Budesonide Sprays Sales by Application
  6. 5.2.1 Global Budesonide Sprays Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Budesonide Sprays Sales by Application (2021-2032)
  8. 5.2.3 Global Budesonide Sprays Sales Market Share by Application (2021-2032)
  9. 5.3 Global Budesonide Sprays Revenue by Application
  10. 5.3.1 Global Budesonide Sprays Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Budesonide Sprays Revenue by Application (2021-2032)
  12. 5.3.3 Global Budesonide Sprays Revenue Market Share by Application (2021-2032)
6 Global Budesonide Sprays Sales by Region
  1. 6.1 Global Budesonide Sprays Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Budesonide Sprays Sales by Region (2021-2032)
  3. 6.2.1 Global Budesonide Sprays Sales by Region (2021-2026)
  4. 6.2.2 Global Budesonide Sprays Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Budesonide Sprays Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Budesonide Sprays Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Budesonide Sprays Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Budesonide Sprays Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Budesonide Sprays Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Budesonide Sprays Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Budesonide Sprays Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Budesonide Sprays Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Budesonide Sprays Revenue by Region
  1. 7.1 Global Budesonide Sprays Revenue by Region
  2. 7.1.1 Global Budesonide Sprays Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Budesonide Sprays Revenue by Region (2021-2026)
  4. 7.1.3 Global Budesonide Sprays Revenue by Region (2027-2032)
  5. 7.1.4 Global Budesonide Sprays Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Budesonide Sprays Revenue (2021-2032)
  8. 7.2.2 North America Budesonide Sprays Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Budesonide Sprays Revenue (2021-2032)
  11. 7.3.2 Europe Budesonide Sprays Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Budesonide Sprays Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Budesonide Sprays Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Budesonide Sprays Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Budesonide Sprays Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Budesonide Sprays Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Budesonide Sprays Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Teva
  14. 8.3.1 Teva Company Information
  15. 8.3.2 Teva Business Overview
  16. 8.3.3 Teva Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Budesonide Sprays Product Portfolio
  18. 8.3.5 Teva Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Budesonide Sprays Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Budesonide Sprays Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Budesonide Sprays Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Budesonide Sprays Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca Budesonide Sprays Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Wellcome Australia Ltd
  50. 8.9.1 Wellcome Australia Ltd Company Information
  51. 8.9.2 Wellcome Australia Ltd Business Overview
  52. 8.9.3 Wellcome Australia Ltd Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Wellcome Australia Ltd Budesonide Sprays Product Portfolio
  54. 8.9.5 Wellcome Australia Ltd Recent Developments
  55. 8.10 Synmosa Biopharma Corporation
  56. 8.10.1 Synmosa Biopharma Corporation Company Information
  57. 8.10.2 Synmosa Biopharma Corporation Business Overview
  58. 8.10.3 Synmosa Biopharma Corporation Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Synmosa Biopharma Corporation Budesonide Sprays Product Portfolio
  60. 8.10.5 Synmosa Biopharma Corporation Recent Developments
  61. 8.11 Squibb
  62. 8.11.1 Squibb Company Information
  63. 8.11.2 Squibb Business Overview
  64. 8.11.3 Squibb Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Squibb Budesonide Sprays Product Portfolio
  66. 8.11.5 Squibb Recent Developments
  67. 8.12 Skyepharma
  68. 8.12.1 Skyepharma Company Information
  69. 8.12.2 Skyepharma Business Overview
  70. 8.12.3 Skyepharma Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Skyepharma Budesonide Sprays Product Portfolio
  72. 8.12.5 Skyepharma Recent Developments
  73. 8.13 Shimadzu Corp
  74. 8.13.1 Shimadzu Corp Company Information
  75. 8.13.2 Shimadzu Corp Business Overview
  76. 8.13.3 Shimadzu Corp Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shimadzu Corp Budesonide Sprays Product Portfolio
  78. 8.13.5 Shimadzu Corp Recent Developments
  79. 8.14 Shanghai Sine Pharmaceutical
  80. 8.14.1 Shanghai Sine Pharmaceutical Company Information
  81. 8.14.2 Shanghai Sine Pharmaceutical Business Overview
  82. 8.14.3 Shanghai Sine Pharmaceutical Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Shanghai Sine Pharmaceutical Budesonide Sprays Product Portfolio
  84. 8.14.5 Shanghai Sine Pharmaceutical Recent Developments
  85. 8.15 Manus Aktteva Biopharma LLP
  86. 8.15.1 Manus Aktteva Biopharma LLP Company Information
  87. 8.15.2 Manus Aktteva Biopharma LLP Business Overview
  88. 8.15.3 Manus Aktteva Biopharma LLP Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Manus Aktteva Biopharma LLP Budesonide Sprays Product Portfolio
  90. 8.15.5 Manus Aktteva Biopharma LLP Recent Developments
  91. 8.16 Lunan Better Pharmaceutical
  92. 8.16.1 Lunan Better Pharmaceutical Company Information
  93. 8.16.2 Lunan Better Pharmaceutical Business Overview
  94. 8.16.3 Lunan Better Pharmaceutical Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Lunan Better Pharmaceutical Budesonide Sprays Product Portfolio
  96. 8.16.5 Lunan Better Pharmaceutical Recent Developments
  97. 8.17 Cipla
  98. 8.17.1 Cipla Company Information
  99. 8.17.2 Cipla Business Overview
  100. 8.17.3 Cipla Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cipla Budesonide Sprays Product Portfolio
  102. 8.17.5 Cipla Recent Developments
  103. 8.18 Chiesi Farmaceutici S.p.A
  104. 8.18.1 Chiesi Farmaceutici S.p.A Company Information
  105. 8.18.2 Chiesi Farmaceutici S.p.A Business Overview
  106. 8.18.3 Chiesi Farmaceutici S.p.A Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Chiesi Farmaceutici S.p.A Budesonide Sprays Product Portfolio
  108. 8.18.5 Chiesi Farmaceutici S.p.A Recent Developments
  109. 8.19 Boehringer Ingelheim
  110. 8.19.1 Boehringer Ingelheim Company Information
  111. 8.19.2 Boehringer Ingelheim Business Overview
  112. 8.19.3 Boehringer Ingelheim Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Boehringer Ingelheim Budesonide Sprays Product Portfolio
  114. 8.19.5 Boehringer Ingelheim Recent Developments
  115. 8.20 Allgen Pharmaceuticals
  116. 8.20.1 Allgen Pharmaceuticals Company Information
  117. 8.20.2 Allgen Pharmaceuticals Business Overview
  118. 8.20.3 Allgen Pharmaceuticals Budesonide Sprays Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Allgen Pharmaceuticals Budesonide Sprays Product Portfolio
  120. 8.20.5 Allgen Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Budesonide Sprays Value Chain Analysis
  2. 9.1.1 Budesonide Sprays Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Budesonide Sprays Production Mode & Process
  6. 9.2 Budesonide Sprays Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Budesonide Sprays Distributors
  9. 9.2.3 Budesonide Sprays Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research